1,535
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Pregnancy and neonatal outcomes following malignancy in pregnancy at a tertiary care Canadian center: a retrospective chart review

, , &
Article: 2198631 | Received 13 Dec 2022, Accepted 29 Mar 2023, Published online: 09 Apr 2023

References

  • Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008;34(4):302–312.
  • Williams TJ, Turnbull KE. Carcinoma in situ and pregnancy. Obstet. Gynecol. 1964;24(6):857–864.
  • Smith LH, Danielsen B, Allen ME, et al. Cancer associated with obstetric delivery: results of linkage with the California cancer registry. Am J Obstet Gynecol. 2003;189(4):1128–1135.
  • Pavlidis NA. Coexistence of pregnancy and malignancy. Oncologist. 2002;7(4):279–287.
  • Pentheroudakis G, Pavlidis N. Cancer and pregnancy: poena magna, not anymore. Eur J Cancer. 2006;42(2):126–140.
  • Parazzini F, Franchi M, Tavani A, et al. Frequency of pregnancy related cancer: a population based linkage study in lombardy, Italy. Int J Gynecol Cancer. 2017;27(3):613–619.
  • Dalmartello M, Negri E, La Vecchia C, et al. Frequency of pregnancy-associated cancer: a systematic review of population-based studies. Cancers. 2020;12(6):1356.
  • Eibye S, Kjær SK, Mellemkjær L. Incidence of pregnancy-associated cancer in Denmark, 1977-2006. Obstet Gynecol. 2013;122(3):608–617.
  • Lee YY, Roberts CL, Dobbins T, et al. Incidence and outcomes of pregnancy-associated cancer in Australia, 1994–2008: a population-based linkage study. BJOG. 2012;119(13):1572–1582.
  • Cottreau CM, Dashevsky I, Andrade SE, et al. Pregnancy-associated cancer: a U.S. Population-based study. J Womens Health. 2019;28(2):250–257.
  • Andersson TML, Johansson ALV, Fredriksson I, et al. Cancer during pregnancy and the postpartum period: a population-based study. Cancer. 2015;121(12):2072–2077.
  • Van Calsteren K, Heyns L, De Smet F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol. 2010;28(4):683–689.
  • Andersson TML, Johansson ALV, Hsieh CC, et al. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol. 2009;114(3):568–572.
  • Maggen C, Wolters VERA, Cardonick E, et al. Pregnancy and cancer: the INCIP project. Curr Oncol Rep. 2020;22(2):17.
  • Peccatori FA, Azim JA, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi160–vi170.
  • Guidroz JA, Scott-Conner CEH, Weigel RJ. Management of pregnant women with breast cancer. J Surg Oncol. 2011;103(4):337–340.
  • PDQ Adult Treatment Editorial Board. Breast Cancer treatment during pregnancy (PDQ®): Health professional version. 2019. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–2019.
  • Wolters V, Heimovaara J, Maggen C, et al. Management of pregnancy in women with cancer. Int J Gynecol Cancer. 2021;31(3):314–322.
  • Botha MH, Rajaram S, Karunaratne K. Cancer in pregnancy. Int J Gynecol Obstet. 2018;143:137–142.
  • Cardonick E, Usmani A, Ghaffar S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am J Clin Oncol. 2010;33(3):221–228.
  • Loibl S, Han SN, von Minckwitz G, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887–896.
  • Zemlickis D, Lishner M, Degendorfer P, et al. Fetal Outcome after in Utero Exposure to Cancer Chemotherapy. Arch Intern Med. 1992;152(3):573–576.
  • de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20-year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337–346.
  • Lu D, Ludvigsson JF, Smedby KE, et al. Maternal cancer during pregnancy and risks of stillbirth and infant mortality. J Clin Oncol. 2017;35(14):1522–1529.
  • Vandenbroucke T, Verheecke M, Van Calsteren K, et al. Fetal outcome after prenatal exposure to chemotherapy and mechanisms of teratogenicity compared to alcohol and smoking. Expert Opin Drug Saf. 2014;13(12):1653–1665.
  • Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283–291.
  • Abenhaim HA, Azoulay L, Holcroft CA, et al. Incidence, risk factors, and obstetrical outcomes of women with breast cancer in pregnancy. Breast J. 2012;18(6):564–568.
  • Gomez-Hidalgo NR, Mendizabal E, Joigneau L, et al. Breast cancer during pregnancy: results of maternal and perinatal outcomes in a single institution and systematic review of the literature. J Obstet Gynaecol. 2019;39(1):27–35.
  • Metcalfe A, Cairncross ZF, Friedenreich CM, et al. Incidence of pregnancy-associated cancer in two Canadian provinces: a population-based study. Int J Environ Res Public Health. 2021;18:1–7.
  • Oake N, Taljaard M, Van Walraven C, et al. The effect of hospital-acquired clostridium difficile infection on in-hospital mortality. Arch Intern Med. 2010;170(20):1804–1810.
  • Murphy MSQ, Fell DB, Sprague AE, et al. Data resource profile: better outcomes registry & network (BORN) Ontario. Int J Epidemiol. 2021;50(5):1416–1417H.
  • Amant F, Vandenbroucke T, Verheecke M, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373(19):1824–1834.